The latest articles and press releases.

 

Milan, Italy, February 5, 2010 more...

Sorin Group announces market release and first implant of next-generation Cardiac Resynchronization Therapy Defibrillator.  

Denver, Colorado, USA - December 3, 2007 more...

The first U.S. enrollment in the OPTION study (Optimal Anti-tachycardia Therapy in ICD Patients without Pacing Indications).  
   
Milan, Italy - September 21, 2007 more...  
Sorin Group: André-Michel Ballester appointed Chief Executive Officer.  
   
Tokyo, Japan - August 31, 2007  more...  
The launch in Japan of the world's smallest line of ICDs: OVATIO.  
   
Denver, Colorado, USA - August 9, 2007  more...  
ELA Medical, Inc., a Sorin Group company announced the first U.S. implant in the NATURE study.  
   
Denver, Colorado, USA – May 11, 2007  more...  
The Sorin Group Announces Release Of 2007 Cardiac Rhythm Management (CRM) Product Performance Report.  
   
Denver, Colorado, USA – May 9, 2007  more...  
The Sorin Group announces European market release of REPLY™, the world’s smallest pacemaker.  
   
Paris, France – April 5, 2007  more...  
After the smallest defibrillator, Sorin is set to launch the world’s smallest pacemaker, confirming its desire for international growth.  
   
Milan, Italy – April 3, 2007  more...  
Sorin Group Names Dick Ames Senior Vice President for USA Cardiac Rhythm Management.  
   
Milan, Italy – March 1, 2007  more...  
The Sorin Group announced today CE Mark approval and first implants of REPLY™ pacemakers, the world’s smallest dual-chamber devices (8cc).  
   
Arvada, CO, USA – December 7, 2006  more...  
Sorin Group files pre-market approval application (PMA) with the United States Food and Drug Administration (FDA) seeking approval to market OVATIO™ CRT.  
   
Paris, France – November 14, 2006  more...  
Sorin Group initiates OPTION (Optimal Antitachycardia Therapy in ICD Patients without Pacing Indication) clinical study in Europe.  
   
Tokyo, Japan – October 4, 2006  more...  
SORIN GROUP expands its presence in the japanese market by introducing advanced defibrillation therapy.  
   
Paris, France – June 19, 2006  more...  
SORIN GROUP initiates multi-center "BITAC" study in europe.  
   
Arvada, CO, USA – June 15, 2006  more...  
SORIN GROUP announces first u.s. implants of ovatio dr implantable cardioverter defibrillators.  
   
Nice, France – June 13, 2006  more...  
SORIN GROUP highlights its latest innovations at cardiostim 2006.  
   
Boston, MA, USA – May 16, 2006  more...  
SORIN GROUP announces FDA approval of world's smallest implantable cardioverter defibrillator.  
   
Mannheim, Germany – April 20, 2006  more...  
SORIN GROUP stresses key role of innovative pacing technology in avoiding unnecessary ventricular pacing at Mannheim cardiology congress.  
   
Toronto, Canada – February 20, 2006  more...  
Ovatio, world's smallest implantable cardioverter defibrillator successfully implanted in Canada.  
   
Paris, France – January 16, 2006  more...  
SORIN GROUP launches world's smallest implantable cardioverter defibrillators in Europe.  
   
Paris, France – December 13, 2005  more...  
SORIN GROUP: 500 patients already have benefited from ELA's noninvasive innovative loop recorder.  
   
Milan, Italy – December 6, 2005  more...  
SORIN GROUP initiates clear study in Europe First Patient with NewLiving CHF Biventricular Pacemaker enrolled in the CLEAR study.  
   
Venice, Italy – October 4, 2005  more...  
SORIN GROUP innovates in the hemodynamic management of heart failure with the european introduction of its new generation cardiac resynchronization therapy products.  
   
 



Documents

Sorin Group CRM Presentation

Performance Report

Fact Sheet

Sorin Group Corporate